MHR Institutional Partners

MHR Fund Management is a New York-based private equity and hedge fund manager founded in 1996 by Dr. Mark Rachesky. The firm specializes in distressed and undervalued opportunities, often employing a control-oriented investment strategy to influence the strategic direction of its portfolio companies. While MHR invests across a broad range of industries, it maintains a significant focus on the life sciences, biotechnology, and healthcare sectors, leveraging Dr. Rachesky's medical background to identify value in complex clinical and regulatory situations. The firm frequently provides capital to companies in transition and maintains active involvement through board representation. Notable healthcare-related investments have included firms such as Emisphere Technologies (acquired by Novo Nordisk), Titan Pharmaceuticals, and Navidea Biopharmaceuticals. MHR manages several billion dollars in assets for a global institutional investor base.